Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Trump administration funding cuts and dismantling of USAID force the focus to shift from elimination back to treatment.

Late last month, a paper in The Lancet Global by a team of researchers led by Maximilian J Wilfinger of the University of ...

In the ongoing fight against HIV, scientists have taken a new step toward long-term control of the virus. Researchers have ...

This isn’t about managing the AIDS pandemic. It’s about ending it — and letting a new generation grow and thrive free of its ...

There are many things we’ve learned from studying the ancient Egyptians. One especially fascinating discovery was evidence of ...

Trump’s “big beautiful” bill will also affect the pharmaceutical industry, while AI startups have pulled in the majority of ...

Medically reviewed by Renita White, MD Mouth and tongue lesions are often one of the first symptoms of human immunodeficiency ...

Warehouses in the US are full of foods that fight malnutrition, while kids go hungry in places like South Sudan.

Six months of prevention -- that's how long Lenacapavir, the new drug for HIV prevention lasts.The Food and Drug Administration approved it last month, and desp ...